[Infections caused by Clostridium difficile]

Enferm Infecc Microbiol Clin. 2013 Apr;31(4):254-63. doi: 10.1016/j.eimc.2012.12.010. Epub 2013 Feb 12.
[Article in Spanish]

Abstract

The epidemiology of Clostridium difficile infections (CDIs) has dramatically changed over the last decade in both North America and Europe, and it has become more frequent, more severe, more refractory to standard therapy, and more likely to relapse. These changes have been associated with the emergence of a "hypervirulent" strain known as BI/NAP1/027 which has become endemic in some areas, although, other hypervirulent genotypes (e.g. PCR ribotype 078) have also been described. To reduce the incidence of CDIs, the diagnostic guidelines on diagnosis and treatment methods have been recently updated. The aim of this review is to highlight the recent epidemiological data on CDIs and to provide an overview of the pathogenicity of the infection, diagnostic approaches, old and new treatment options, and current knowledge of infection control measures.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Bacterial Toxins / metabolism
  • Bacteriological Techniques
  • Biological Therapy
  • Carrier State
  • Clostridioides difficile* / classification
  • Clostridioides difficile* / drug effects
  • Clostridioides difficile* / isolation & purification
  • Clostridioides difficile* / pathogenicity
  • Clostridioides difficile* / physiology
  • Clostridium Infections / diagnosis
  • Clostridium Infections / epidemiology
  • Clostridium Infections / microbiology*
  • Clostridium Infections / prevention & control
  • Clostridium Infections / therapy
  • Colectomy
  • Combined Modality Therapy
  • Cross Infection / epidemiology
  • Cross Infection / microbiology
  • Diagnosis, Differential
  • Disease Susceptibility
  • Enterocolitis, Pseudomembranous / epidemiology
  • Enterocolitis, Pseudomembranous / microbiology
  • Enterocolitis, Pseudomembranous / prevention & control
  • Europe / epidemiology
  • Feces / microbiology
  • Humans
  • North America / epidemiology
  • Recurrence
  • Ribotyping
  • Risk Factors
  • Virulence

Substances

  • Anti-Bacterial Agents
  • Bacterial Toxins